Comments
Loading...
Merck & Co Stock Guidance | NYSE:MRK | Benzinga
Merck & Co issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/24/2025 | MRK | Merck & Co | FY | 2025 | $8.82 | $8.97 | $8.94 | $64.10B | $65.60B | $65.01B | Get Alert |
| 02/04/2025 | MRK | Merck & Co | FY | 2025 | $8.88 | $9.03 | $9.23 | $64.10B | $65.60B | $67.36B | Get Alert |
| 10/31/2024 | MRK | Merck & Co | FY | 2024 | $7.72 | $7.77 | $7.74 | $63.60B | $64.10B | $64.16B | Get Alert |
| 07/30/2024 | MRK | Merck & Co | FY | 2024 | $7.94 | $8.04 | $8.16 | $63.40B | $64.40B | $64.34B | Get Alert |
| 04/25/2024 | MRK | Merck & Co | FY | 2024 | $8.53 | $8.65 | $8.56 | $63.10B | $64.30B | $63.83B | Get Alert |
| 02/01/2024 | MRK | Merck & Co | FY | 2024 | $8.44 | $8.59 | $8.42 | $62.70B | $64.20B | $63.52B | Get Alert |
| 10/26/2023 | MRK | Merck & Co | FY | 2023 | $1.33 | $1.38 | $2.86 | $59.70B | $60.20B | $55.98B | Get Alert |
| 08/01/2023 | MRK | Merck & Co | FY | 2023 | $2.95 | $3.05 | $2.60 | $58.60B | $59.60B | $53.18B | Get Alert |
| 04/27/2023 | MRK | Merck & Co | FY | 2023 | $6.88 | $7.00 | $6.91 | $57.70B | $58.90B | $58.28B | Get Alert |
| 02/02/2023 | MRK | Merck & Co | FY | 2023 | $6.80 | $6.95 | $7.36 | $57.20B | $58.70B | $58.07B | Get Alert |
| 10/27/2022 | MRK | Merck & Co | FY | 2022 | $7.32 | $7.37 | $7.34 | $58.50B | $59.00B | $58.51B | Get Alert |
| 07/28/2022 | MRK | Merck & Co | FY | 2022 | $7.25 | $7.35 | $7.36 | $57.50B | $58.50B | $58.10B | Get Alert |
| 04/28/2022 | MRK | Merck & Co | FY | 2022 | $7.24 | $7.36 | $7.24 | $56.90B | $58.10B | $57.35B | Get Alert |
| 02/03/2022 | MRK | Merck & Co | FY | 2022 | $7.12 | $7.27 | $7.29 | $56.10B | $57.60B | $56.64B | Get Alert |
| 10/28/2021 | MRK | Merck & Co | FY | 2021 | $5.65 | $5.70 | $5.77 | $47.40B | $47.90B | $48.16B | Get Alert |
| 07/29/2021 | MRK | Merck & Co | FY | 2021 | $5.47 | $5.57 | $6.15 | $46.40B | $47.40B | $48.59B | Get Alert |
| 04/29/2021 | MRK | Merck & Co | FY | 2021 | $6.48 | $6.68 | $6.57 | $51.80B | $53.80B | $52.51B | Get Alert |
| 02/04/2021 | MRK | Merck & Co | FY | 2021 | $6.48 | $6.68 | $6.41 | $51.80B | $53.80B | $51.77B | Get Alert |
| 10/27/2020 | MRK | Merck & Co | FY | 2020 | $5.91 | $6.01 | $5.71 | $47.60B | $48.60B | $48.00B | Get Alert |
FAQ
What is the most recent guidance for Merck & Co (MRK)?
The most recent guidance for Merck & Co (MRK) was reported on April 24, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $8.82 to $8.97, compared to the estimated EPS of $8.94. Additionally, Merck & Co forecasted revenue between $64.10B and $65.60B for the quarter.
Browse guidance and forecast on all stocks.
